Last updated on May 2020

A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis


Brief description of study

The reason for this study is to see if the study drug called baricitinib works and is safe in children and teenage participants with atopic dermatitis.

Clinical Study Identifier: NCT03952559

Find a site near you

Start Over